Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.

Wang J, Welch K, Wang L, Kong FM.

Clin Lung Cancer. 2012 Mar;13(2):81-9. doi: 10.1016/j.cllc.2011.08.002. Epub 2011 Nov 3.

2.

False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.

Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.

Eur J Cardiothorac Surg. 2012 Jul;42(1):93-100; discussion 100. doi: 10.1093/ejcts/ezr272. Epub 2012 Jan 20.

PMID:
22290911
3.

Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.

Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Gu CS, Kuruvilla MS, Cline KJ, Julian JA, Evans WK, Levine MN.

J Thorac Oncol. 2011 Aug;6(8):1367-72. doi: 10.1097/JTO.0b013e318220c912. Erratum in: J Thorac Oncol. 2012 Mar;7(3):628.

4.

Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?

Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.

Thorac Cardiovasc Surg. 2012 Mar;60(2):116-21. doi: 10.1055/s-0030-1271148. Epub 2011 Jun 20.

PMID:
21692019
5.

Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.

Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.

Radiology. 2006 Nov;241(2):501-9. Epub 2006 Sep 11.

PMID:
16966480
6.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
7.

Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.

Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.

Clin Lung Cancer. 2013 Sep;14(5):568-73. doi: 10.1016/j.cllc.2013.02.002. Epub 2013 Jul 5.

PMID:
23835164
8.

Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.

Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW.

Respirology. 2010 Nov;15(8):1179-84. doi: 10.1111/j.1440-1843.2010.01793.x.

PMID:
20573058
10.

Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.

Taus Á, Aguiló R, Curull V, Suárez-Piñera M, Rodríguez-Fuster A, Rodríguez de Dios N, Pijuan L, Zuccarino F, Vollmer I, Sánchez-Font A, Belda-Sanchis J, Arriola E.

Arch Bronconeumol. 2014 Mar;50(3):99-104. doi: 10.1016/j.arbres.2013.09.017. Epub 2013 Dec 19. English, Spanish.

11.

Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.

Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.

Int J Cancer. 2013 Jan 15;132(2):E37-47. doi: 10.1002/ijc.27779. Epub 2012 Sep 1.

12.

Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.

Akthar AS, Ferguson MK, Koshy M, Vigneswaran WT, Malik R.

Technol Cancer Res Treat. 2017 Feb;16(1):15-21. doi: 10.1177/1533034615624045. Epub 2016 Jun 23.

14.

PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.

Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P; Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.

Eur J Cardiothorac Surg. 2001 Sep;20(3):468-74; discussion 474-5.

PMID:
11509265
15.

Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK.

Ann Thorac Surg. 2007 Jul;84(1):177-81.

PMID:
17588407
16.

The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

Clin Nucl Med. 2007 Aug;32(8):607-12.

PMID:
17667432
17.

The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.

Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA.

Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):200-3. doi: 10.1510/icvts.2009.220392. Epub 2009 Nov 19.

PMID:
19933240
18.

Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.

Gao SJ, Kim AW, Puchalski JT, Bramley K, Detterbeck FC, Boffa DJ, Decker RH.

Lung Cancer. 2017 Jul;109:36-41. doi: 10.1016/j.lungcan.2017.04.018. Epub 2017 Apr 25.

PMID:
28577947
19.

Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.

Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.

Radiother Oncol. 2012 Feb;102(2):246-50. doi: 10.1016/j.radonc.2011.10.016. Epub 2011 Nov 17.

PMID:
22100657
20.

Supplemental Content

Support Center